DK2403
DK2403 (compound 25) is a MAP2K7 inhibitor (IC50= 0.01 μM) . DK2403 can effectively inhibit MAP2K7 without significantly disrupting the larger kinase group and can be used to study childhood T-cell acute lymphoblastic leukemia[1].
Product Specifications
CAS Number
2902651-64-1
UNSPSC
12352005
Target
P38 MAPK
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
98.24
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(CCl)NC1=CC(OC2=NC=NC(NCC3=CC=CC=C3)=C2)=CC=C1
Molecular Formula
C19H17ClN4O2
Molecular Weight
368.82
References & Citations
[1]Kim DR, et al. Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors. ACS Med Chem Lett. 2023 Apr 17;14 (5) :606-613.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC213555L4V 200 µL
EXOSC10 (NM_002685) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 